EC Healthcare
HKEX:2138.HK
0.82 (HKD) • At close September 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,211.034 | 3,875.377 | 2,919.5 | 2,080.403 | 1,948.501 | 1,852.452 | 1,322.141 | 974.903 | 707.92 | 621.353 | 489.897 | 234.71 |
| Cost of Revenue
| 3,506.293 | 3,200.711 | 2,166.451 | 1,560.937 | 1,298.566 | 880.956 | 615.061 | 485.827 | 315.822 | 260.621 | 247.066 | 171.199 |
| Gross Profit
| 704.741 | 674.666 | 753.049 | 519.467 | 649.934 | 971.496 | 707.08 | 489.076 | 392.098 | 360.731 | 242.831 | 63.511 |
| Gross Profit Ratio
| 0.167 | 0.174 | 0.258 | 0.25 | 0.334 | 0.524 | 0.535 | 0.502 | 0.554 | 0.581 | 0.496 | 0.271 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 219.151 | 232.371 | 161.428 | 115.998 | 186.262 | 222.302 | 157.822 | 118.542 | 75.77 | 67.965 | 83.558 | 46.902 |
| Selling & Marketing Expenses
| 207.222 | 172.715 | 139.383 | 109.381 | 124.443 | 154.538 | 126.932 | 68.461 | 38.018 | 23.928 | 23.805 | 28.434 |
| SG&A
| 599.959 | 548.659 | 421.998 | 332.56 | 310.705 | 376.84 | 300.524 | 187.003 | 123.18 | 111.459 | 107.363 | 75.336 |
| Other Expenses
| -40.537 | -40.073 | -40.968 | -35.891 | 3.621 | -128.124 | -89.941 | 9.976 | -46.546 | -39.492 | 0 | 0 |
| Operating Expenses
| 599.959 | 548.659 | 421.998 | 332.56 | 307.084 | 535.703 | 389.183 | 248.98 | 209.176 | 152.387 | 147.814 | 95.425 |
| Operating Income
| 104.782 | 126.007 | 331.051 | 186.907 | 342.85 | 439.383 | 302.59 | 230.887 | 218.316 | 212.048 | 91.333 | -34.322 |
| Operating Income Ratio
| 0.025 | 0.033 | 0.113 | 0.09 | 0.176 | 0.237 | 0.229 | 0.237 | 0.308 | 0.341 | 0.186 | -0.146 |
| Total Other Income Expenses Net
| -93.334 | -2.146 | -8.972 | 74.003 | 17.552 | 10.697 | 27.564 | 13.721 | -33.909 | -1.451 | 5.336 | 3.119 |
| Income Before Tax
| 11.448 | 123.861 | 322.079 | 260.909 | 360.402 | 450.08 | 330.154 | 244.608 | 184.408 | 210.597 | 96.669 | -31.204 |
| Income Before Tax Ratio
| 0.003 | 0.032 | 0.11 | 0.125 | 0.185 | 0.243 | 0.25 | 0.251 | 0.26 | 0.339 | 0.197 | -0.133 |
| Income Tax Expense
| 1.179 | 29.162 | 50.908 | 40.303 | 50.251 | 65.576 | 52.017 | 41.112 | 35.099 | 35.819 | 15.262 | 2.028 |
| Net Income
| -18.947 | 69.654 | 197.501 | 192.865 | 286.576 | 361.106 | 279.224 | 200.703 | 148.664 | 174.415 | 81.122 | -32.301 |
| Net Income Ratio
| -0.004 | 0.018 | 0.068 | 0.093 | 0.147 | 0.195 | 0.211 | 0.206 | 0.21 | 0.281 | 0.166 | -0.138 |
| EPS
| -0.016 | 0.059 | 0.17 | 0.19 | 0.29 | 0.37 | 0.28 | 0.21 | 0.2 | 0.24 | 0.11 | -0.044 |
| EPS Diluted
| -0.016 | 0.059 | 0.17 | 0.19 | 0.29 | 0.37 | 0.28 | 0.21 | 0.2 | 0.24 | 0.11 | -0.044 |
| EBITDA
| 730.327 | 712.742 | 763.416 | 496.77 | 588.634 | 501.128 | 340.215 | 260.061 | 242.958 | 230.201 | 107.042 | -24.563 |
| EBITDA Ratio
| 0.173 | 0.184 | 0.261 | 0.239 | 0.302 | 0.271 | 0.257 | 0.267 | 0.343 | 0.37 | 0.218 | -0.105 |